Skip to main content
Download PDF

Retraction Note: The stem cell factor antibody enhances the chemotherapeutic effect of adriamycin on chemoresistant breast cancer cells

Cancer Cell International volume 13, Article number: 96 (2013) Cite this article

The Original Article was published on 29 May 2012

Retraction

This article has been retracted [1] by the authors because errors were noted in the methodology employed in the experiments which invalidate the results reported. The authors apologise for any inconvenience caused.

References

  1. Jelly ND, Hussain II, Eremin J, Eremin O, El-Sheemy M: The stem cell factor antibody enhances the chemotherapeutic effect of adriamycin on chemoresistant breast cancer cells. Cancer Cell Int. 2012, 12: 21-10.1186/1475-2867-12-21.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Lincoln, Brayford Pool, Lincoln, LN6 7TS, UK

    Neil D Jelly, Issam I Hussain & Mohamed El-Sheemy

  2. Research & Development, Lincoln County Hospital, Greetwell Road, Lincoln, LN2 5QY, UK

    Jennifer Eremin, Oleg Eremin & Mohamed El-Sheemy

  3. Queens Medical Centre, University of Nottingham, Derby Road Nottingham, Nottingham, NG7 2UH, UK

    Oleg Eremin

Authors
  1. Neil D Jelly
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Issam I Hussain
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jennifer Eremin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Oleg Eremin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mohamed El-Sheemy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Neil D Jelly.

Additional information

The online version of the original article can be found at 10.1186/1475-2867-12-21

Rights and permissions

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

About this article

Cite this article

Jelly, N.D., Hussain, I.I., Eremin, J. et al. Retraction Note: The stem cell factor antibody enhances the chemotherapeutic effect of adriamycin on chemoresistant breast cancer cells. Cancer Cell Int 13, 96 (2013). https://doi.org/10.1186/1475-2867-13-96

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/1475-2867-13-96

Cancer Cell International

ISSN: 1475-2867

Contact us